Clinical Trials Directory

Trials / Completed

CompletedNCT05164445

The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

Observational Participants Not Assigned to Intervention(s) Based on a Protocol; Typically in Context of Routine Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Lithuanian University of Health Sciences · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study is designed to evaluate complications, specificity, diagnostic yield of radial endobronchial ultrasound guided transbronchial cryobiopsy and transbronchial forceps biopsy with fluoroscopy in the diagnosis of peripheral pulmonary lesion; the interplay between non-small-cell lung cancer associated-bacteria along the gut-lung axis and immune response in the cancer microenvironment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTransbronchial forceps biopsyAll patients with peripheral lung lesion suspected of lung cancer detected on the chest computed tomography (CT) and mini probe endobronchial ultrasound (RP-EBUS) scans were enrolled. Transbronchial forceps biopsy (TBFB) was performed for all these patients.
DIAGNOSTIC_TESTTransbronchial forceps biopsy+Transbronchial cryobiopsyAll patients with peripheral lung lesion suspected of lung cancer detected on the chest computed tomography (CT) and RP-EBUS scans were enrolled. TBFB was performed for all these patients. In addition, all of these patients, with no contraindications, underwent transbronchial cryobiopsy (TBCB)

Timeline

Start date
2019-09-01
Primary completion
2023-02-01
Completion
2023-08-31
First posted
2021-12-20
Last updated
2023-10-04

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT05164445. Inclusion in this directory is not an endorsement.